Bone and Calcium Metabolism in Subclinical Autoimmune Hyperthyroidism and Hypothyroidism

Endocrine Journal

Volumn 50, Issue 6, 2003, Pages 657-661

  Kisakol, Gurcan ^a   Kaya, Ahmet ^a   Gonen, Sait ^a   Tunc, Recep ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Bone markers; Bone metabolism; Bone turnover; Subclinical hyperthyroidism; Subclinical hypothyroidism

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PHOSPHORUS; THYROID HORMONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM METABOLISM; CALCIUM MOBILIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; FEMALE; GRAVES DISEASE; HIGH RISK PATIENT; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; OSTEOLYSIS; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; TRABECULAR BONE;

ADULT; AMINO ACIDS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; CALCIUM; CASE-CONTROL STUDIES; FEMALE; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; MALE; THYROID HORMONES;

EID: 0942276916     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.657     Document Type: Article

References (19)

1. Koutras DA (1999) Subclinical hyperthyroidism. Thyroid 9: 311-315.
2. Canaris GJ, Manowitz NR, Mayor GM, Ridgway EC (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160: 526-534.
3. Akalin A, Colak O, Alatas O, Efe B (2002) Bone remodelling markers and serum cytokines in patients with hyperthyroidism. Clin Endocrinol (Oxf) 57: 125-129.
4. Rizzoli R, Poser J, Bürgi U (1986) Nuclear thyroid hormone receptors in cultured bone cells. Metabolism 35: 71-74.
5. Sato K, Han DC, Fujii Y, Tsushima T, Shizume K (1987) Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3′-triiodo-L-thyronine nuclear receptors. Endocrinology 120: 1873-1881.
6. Riggs BL, Melton III LJ (1986) Involutional osteoporosis. N Engl J Med 314: 1676-1686.
7. Nagasaka S, Sugimoto H, Nakamura T, Kusaka I, Fujisawa G, Sakuma N (1997) Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis. Clin Endocrinol (Oxf) 47: 215-217.
8. Coindre JM, David JP, Riviere L, Goussot JF, Roger P, de Mascarel A, Meunier PJ (1986) Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med 146: 48-53.
9. Nuzzo V, Lupoli G, Esposito Del Puente A, Rampone E, Carpinelli A, Del Puente AE, Oriente P (1998) Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy. Gynecol Endocrinol 12: 333-337.
10. Engler H, Oettli RE, Riesen WF (1999) Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study. Clin Chim Acta 289: 159-172.
11. Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y (2000) Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab 85: 4157-4161.
12. Faber J, Jensen IW, Petersen L, Nygaard B, Hegedus L, Siersbaek-Nielsen K (1998) Normalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol (Oxf) 48: 285-290.
13. Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19: 35-63.
14. Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85: 1099-1106.
15. Inoue M, Tawata M, Yokomori N, Endo T, Onaya T (1998) Expression of thyrotropin receptor on clonal osteoblast-like rat osteosarcoma cells. Thyroid 8: 1059-1064.
16. De Menis E, Da Rin G, Roiter I, Legovini P, Foscolo G, Conte N (1992) Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma. Horm Res 37: 217-220.
17. Gurlek A, Gedik O (1999) Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid 9: 539-543.
18. Arata N, Momotani N, Maruyama H, Saruta T, Tsukatani K, Kubo A, Ikemoto K, Ito K (1997) Bone mineral density after surgical treatment for Graves' disease. Thyroid 7: 547-554.
19. Bouillon R, Muls E, De Moor P (1980) Influence of thyroid function on the concentration of 1,25-dihydroxy-vitamin D3. J Clin Endocrinol Metab 51: 793-797.